Chemical synthesis study demonstrates enantioselective cycloaddition of fluoroalkyl ketones with bicyclo[1.1.0]butanes via chiral boron catalysis, highlighting a route to complex drug bioisosteres.
Bicyclo[2.1.1]hexanes (BCHs), three-dimensional benzene bioisosteres characterized by high sp3 carbon content, hold great promise for diverse applications in medicinal chemistry. While racemic BCH synthesis has advanced significantly, highly enantioselective approaches are still comparatively scarce. Here, we report an enantioselective [2π+2σ] cycloaddition of β-fluoroalkyl-α,β-unsaturated ketones with bicyclo[1.1.0]butanes (BCBs) catalyzed by a chiral (R)-3,3′-(3,5-(CF3)2-C6H3)2-BINOL–boron complex. This approach overcomes major limitations of existing metal-catalyzed and photochemical methods. This transformation provides BCH derivatives featuring CF3- or C2F5-bearing stereocenters in moderate to high yields with excellent diastereo- and enantioselectivities (up to >20:1 dr and >99% ee). This mild catalytic protocol exhibits a broad substrate scope and enables the rapid construction of complex fluoroalkyl-containing BCH scaffolds.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: